These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 728322)

  • 1. The features of hepatic enzyme induction with glutethimide in man.
    Jackson L; Homeida M; Roberts CJ
    Br J Clin Pharmacol; 1978 Dec; 6(6):525-8. PubMed ID: 728322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in D-glucaric acid excretion in relationship to alterations in the rate of antipyrine metabolism in man.
    Hunter J; Burnham WR; Chasseaud LF; Down W
    Biochem Pharmacol; 1974 Sep; 23(17):2480-3. PubMed ID: 4429583
    [No Abstract]   [Full Text] [Related]  

  • 3. Enzyme induction and serum and lipoprotein lipids: a study of glutethimide in normal subjects.
    Bolton CH; Jackson L; Roberts CJ; Hartog M
    Clin Sci (Lond); 1980 May; 58(5):419-21. PubMed ID: 7389270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-adrenoceptor blocking drugs and cytochrome P-450: the influence of propranolol treatment on caffeine, antipyrine, D-glucaric acid and indocyanine green elimination in patients with hepatic disorders.
    Traeger A; Horváth T; Rechenbach C; Jávor T
    Int J Clin Pharmacol Res; 1986; 6(3):235-9. PubMed ID: 3744626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug induction of hepatic enzymes in the elderly.
    Pearson MW; Roberts CJ
    Age Ageing; 1984 Sep; 13(5):313-6. PubMed ID: 6496244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary D-glucaric acid excretion during rifampicin/isoniazid and anticonvulsant enzyme induction.
    Perry W; Stamp TC
    Clin Pharmacol Ther; 1984 May; 35(5):710-5. PubMed ID: 6143635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of rifampicin on drug metabolism: differences between hexobarbital and antipyrine.
    Breimer DD; Zilly W; Richter E
    Clin Pharmacol Ther; 1977 Apr; 21(4):470-81. PubMed ID: 849678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between liver volume, antipyrine clearance and indocyanine green clearance before and after phenobarbitone administration in man.
    Roberts CJ; Jackson L; Halliwell M; Branch RA
    Br J Clin Pharmacol; 1976 Oct; 3(5):907-13. PubMed ID: 973986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme induction and renal function in man.
    Ohnhaus EE; Martin J; Kinser J; Colombo JP
    Br J Clin Pharmacol; 1977 Feb; 4(1):33-7. PubMed ID: 843422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of alphamethyldopa on the half-lives of antipyrine, tolbutamide and D-glucaric acid excretion in man.
    Gachályi B; Tornyossy M; Vas A; Káldor A
    Int J Clin Pharmacol Ther Toxicol; 1980 Mar; 18(3):133-5. PubMed ID: 6103880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Note on the enzyme assay for urinary D-glucaric acid and correlation with rifampicin-induced mixed function oxidase activity.
    Perry W; Jenkins MV
    Int J Clin Pharmacol Ther Toxicol; 1986 Nov; 24(11):609-13. PubMed ID: 3793294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipyrine pharmacokinetics and D-glucaric excretion in kwashiorkor.
    Buchanan N; Eyberg C; Davis MD
    Am J Clin Nutr; 1979 Dec; 32(12):2439-42. PubMed ID: 506967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. m-Trifluoromethyl-alpha-ethylbenzhydrol: a new enzyme inducer.
    Gachályi B; Káldor A; Szeberényi S
    Eur J Clin Pharmacol; 1978 Jun; 13(4):299-302. PubMed ID: 668788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutethimide and enzyme induction.
    Roberts C; Jackson L; Homeida M
    Br Med J; 1976 Nov; 2(6046):1256-7. PubMed ID: 990872
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
    Branch RA; Shand DG; Wilkinson GR; Nies AS
    J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver blood flow and enzyme induction in man.
    Ohnhaus EE; Noelpp UB; Ramos MR
    Hepatogastroenterology; 1985 Apr; 32(2):61-4. PubMed ID: 4007764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of antipyrine and lignocaine disposition in normal subjects and in patients treated with enzyme-inducing drugs.
    Perucca E; Hedges A; Makki KA; Richens A
    Br J Clin Pharmacol; 1980 Nov; 10(5):491-7. PubMed ID: 7437261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of enzyme induction on diazepam metabolism in man.
    Ohnhaus EE; Park BK; Colombo JP; Heizmann P
    Br J Clin Pharmacol; 1979 Dec; 8(6):557-63. PubMed ID: 42427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of hepatic drug metabolism by glutethimide in patients with liver disease.
    Farrell GC; Cooksley WG; Powell LW
    Eur J Clin Pharmacol; 1979 Sep; 16(2):113-7. PubMed ID: 499307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human tolerance of flumecinol (Zixoryn, RGH-3332), its regime and dosage in healthy volunteers.
    Vezekenyi Z; Ferenci J; Radnai B; Horvath T; Past T; Nagy L; Jávor T
    Int J Clin Pharmacol Res; 1983; 3(2):77-88. PubMed ID: 6679516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.